LSD molecule:

Image from PubChem

LSD Clinical Trials

A Randomized, Double-Blind, Placebo- And Active-Controlled Single-Dose, Crossover Study To Evaluate The Abuse Potential Of Single Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users

To see complete record on, please visit this link

Id: NCT00975481

Organisation Name: Pfizer

Overal Status: Completed

Start Date: October 2009

Last Update: April 2, 2013

Lead Sponsor: Pfizer

Brief Summary: Dimebon will not exhibit abuse potential when compared to placebo or a positive control (alprazolam).

  • Alzheimer's Disease
  • Huntington's Disease

Total execution time in seconds: 0.32871007919312